Approval · Notice of Compliance 982 · 2000
ALPROSTADIL INJECTION: Notice of Compliance 982
Issued February 11, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 982
- Date
- February 11, 2000
- Company
- Novopharm LimitedMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Prostaglandin
- Canadian reference product
- PROSTINE VR STERILE SOLUTION (Pharmacia & Upjohn Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALPROSTADIL INJECTION | 02241680 | Cancelled Post Market |
Medicinal ingredients
- ALPROSTADIL 0.5 MG per 1ML